Malaysia and Taiwan are the two countries in Asia most exposed to Trump’s threatened 100% tariffs on semiconductors. However, exemptions for companies with production facilities in the US and limited US chip capacity should ease the overall impact. Singapore is the most vulnerable country to higher pharmaceutical tariffs. However, the fact that demand is price-insensitive and that tariffs are only likely to be phased in gradually means that any hit to GDP will be relatively small, at least in the near term. Meanwhile, plans to increase tariffs on India could shift investment toward lower-tariff neighbours, including Vietnam, Indonesia, and the Philippines.
How is global economic fracturing unfolding in Trump’s second term? Join our economists for in-person briefings on the macro and market risks around the breakdown in US-China relations and the reordering of the world economy. Register for events in Singapore (3rd Sept.) and Hong Kong (4th Sept.).
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services